← Back to Clinical Trials
Recruiting NCT06605001

NCT06605001 Development, Attention, and Inhibition Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06605001
Status Recruiting
Phase
Sponsor University of California, Davis
Condition The Ability to Delay Gratification
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2024-08-21
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 4 Years
Max Age 7 Years
Study Type INTERVENTIONAL
Interventions
Delay of Gratification

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2024-08-21 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to test the associations of young children's early life experiences with delaying behaviors and links with later life outcomes. The main questions it aims to answer are: * Do experiences with waiting in early childhood predict delaying behavior in context-specific ways? * Are links between delaying behavior and life outcomes impacted by social conventions, effort and choices around delaying, or other behaviors? Participants will: * Complete two delaying tasks with either a sweet or wrapped gift * Complete three "Simon says"-like games that measure inhibition, cognitive flexibility and proactive control * Answer a set of questions about academic readiness * Answer a set of questions about social conventions * Complete a waiting game on the computer while a camera records eye movements * Parents will answer questions about their child's behaviors and experiences at home * Participants will return after 1 year to repeat a subset of these measures

Eligibility Criteria

Typically developing children will be recruited. Participants will be pre-screened for developmental disorders.

Contact & Investigator

Central Contact

Rachel Foster, B.S.

✉ refoster@ucdavis.edu

📞 +1 530 754 4551

Principal Investigator

Rachel Foster, B.S.

STUDY DIRECTOR

University of California, Davis

Frequently Asked Questions

Who can join the NCT06605001 clinical trial?

This trial is open to participants of all sexes, aged 4 Years or older, up to 7 Years, studying The Ability to Delay Gratification. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06605001 currently recruiting?

Yes, NCT06605001 is actively recruiting participants. Contact the research team at refoster@ucdavis.edu for enrollment information.

Where is the NCT06605001 trial being conducted?

This trial is being conducted at Davis, United States.

Who is sponsoring the NCT06605001 clinical trial?

NCT06605001 is sponsored by University of California, Davis. The principal investigator is Rachel Foster, B.S. at University of California, Davis. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology